Info
Insider Ownership

Insider Trading & Ownership of Samuel C. Blackman

Location: 395 Oyster Point Blvd., Suite 217, South San Francisco, CA
Summary: The estimated net worth of Samuel C. Blackman is at least $29.4M dollars as of December 12, 2024. Samuel C. Blackman is the HEAD OF R&D of Day One Biopharmaceuticals, Inc. and owns shares of Day One Biopharmaceuticals, Inc. (DAWN) stock worth about $29.4M.
Signature: /s/ Charles N. York II, as Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when Samuel C. Blackman files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Samuel C. Blackman

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
DAWN	Day One Biopharmaceuticals, Inc.	Head Of R&D	$29.4M			Dec 10, 2024

Insider Transactions Reported by Samuel C. Blackman:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.